Insider Transactions Reported by 17 Insiders of Pasithea Therapeutics Corp.

Symbol
KTTA, KTTAW on Nasdaq
Location
Miami Beach, FL

Insiders trading volume in the past year

Pasithea Therapeutics Corp. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
PD Joint Holdings, LLC Series 2016-A 10%+ Owner $1,124,348 22 Oct 2022
Eric Shahinian Member of 10% owner group $770,807 28 Sep 2022
Israel Maxx Abramowitz Not a 10% owner $453,229 14 Sep 2021
Eric Lazer Not a 10% owner $389,021 14 Sep 2021
Dean Lazer Not a 10% owner $389,021 14 Sep 2021
Lawrence Steinman Director $149,768 +$100,000 +201% 28 Nov 2025
Dr. Yassine Bendiabdallah Chief Operating Officer, Director $129,300 14 Sep 2021
David Delaney Member of 10% owner group $98,062 17 Oct 2022
Dr. Tiago Reis Marques Chief Executive Officer, Director $55,000 +$24,208 +79% 28 Nov 2025
Simon Dumesnil Director $26,874 +$25,000 +1334% 28 Nov 2025
Dr. Emer Leahy Director $24,999 28 Nov 2025
Avi Geller Member of 10% owner group $23,552 19 Aug 2022
Daniel Schneiderman Chief Financial Officer $20,000 28 Nov 2025
Leonite Fund I, LP Member of 10% owner group 19 Aug 2022
Graeme Currie Chief Development Officer 01 Mar 2024
Stanley M. Gloss Chief Financial Officer 14 Sep 2021
Alfred J. Novak Director 24 Oct 2025

Recent Insider Transactions by Companies or Individuals for Pasithea Therapeutics Corp.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.